SSL Seguro
Retatrutide - Metabolic Health product image 1 of 13 - Prost Biotech
Metabolic Health

Retatrutide

Investigational triple hormone receptor agonist (GIP/GLP-1/Glucagon) educational resource for qualified metabolic health research inquiries.

Latest Batch Verified

Lot BSL022026 · Tested Feb 23, 2026

HPLC purity, identity (MS), endotoxin, heavy metals — all specs passed. Spec table + per-test methodology available on the public COA page.

View Full COA Test Report

Consulta por Atacado

10+ frascos · OEM / Marca Própria · Envio em Cadeia de Frio

Orçamento de Fábrica no WhatsApp

Retatrutide is an investigational triple hormone receptor agonist that activates GIP, GLP-1, and glucagon receptors simultaneously. This page summarizes the molecule and 20mg format for qualified professional research inquiries; it is not presented as an approved consumer treatment.

Available Dosages

Retatrutide 20mg dosage variant - Metabolic Health formulation by Prost Biotech

20mg

Multi-dose vial for clinic administration

Key Benefits

  • Triple receptor agonist (GIP/GLP-1/Glucagon)
  • 20mg vial for flexible clinic dosing
  • Clinical-trial-stage metabolic research molecule
  • Multi-pathway metabolic activation
  • Professional research and clinic inquiry resource
  • Next-generation investigational therapeutic class

Scientific Background

Retatrutide activates three hormone receptor pathways: GIP, GLP-1, and glucagon. Published clinical research is still evolving, and regulatory status should be reviewed carefully before any clinical or commercial use.

View Reference Guide

Educational Display Only
This product information is for educational purposes. Always consult licensed healthcare providers for personalized medical advice.

Frequently Asked Questions